Caris Life Sciences, Inc. CAI
32.85 USD +0.75 (+2.34%)
At closeNov 3, 2026, 7:57 PM EST
32.78 -0.07 -0.21%
After hours · Nov 3, 7:57 PM ET
32.14 Day range 34.00
14.19 52-week range 36.50
- YTD
- +21.76%
- 1 year
- +9.72%
Analyst view
Consensus: buy
Buy
Price target (mean) 32.46 -1.2% downside
Now 32.85
- Target (low)
- 22.00
- Target (mean)
- 32.46
- Target (high)
- 38.00
Ratings (0m) 14 10 buy · 4 hold · 0 sell
- Strong buy1
- Buy9
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.02012 | -0.00514 – 0.07 | 0.08 | -74.9% | 255.34M | +17.8% | 10 |
| Next quarter | 0.1122 | 0.05 – 0.19024 | 0.28 | -59.9% | 294.87M | +0.7% | 10 |
| Current year | 0.13801 | 0.04 – 0.26358 | -0.40721 | +133.9% | 1.03B | +26.8% | 11 |
| Next year | 0.37192 | 0.05 – 0.52178 | 0.13801 | +169.5% | 1.23B | +19.3% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 19, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Oct 14, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Sep 9, 2026 | UBS | Initiated | — | Neutral |
| Aug 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 6, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 5, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 2, 2026 | BTIG | Reiterated | Buy | Buy |
| May 8, 2026 | Citigroup | Maintained | Buy | Buy |
| May 8, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 8, 2026 | BTIG | Maintained | Buy | Buy |
| Apr 13, 2026 | Jefferies | Initiated | — | Buy |
| Apr 10, 2026 | Piper Sandler | Initiated | — | Neutral |
| Apr 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Mar 13, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Feb 27, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Feb 27, 2026 | Baird | Maintained | Outperform | Outperform |
| Feb 27, 2026 | BTIG | Maintained | Buy | Buy |
| Feb 17, 2026 | Baird | Initiated | — | Outperform |
| Dec 22, 2025 | Canaccord Genuity | Maintained | Hold | Hold |
| Dec 2, 2025 | Canaccord Genuity | Initiated | — | Hold |
| Aug 13, 2025 | Guggenheim | Maintained | Buy | Buy |
| Aug 13, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 13, 2025 | Citigroup | Maintained | Buy | Buy |
| Jul 15, 2025 | Evercore ISI Group | Initiated | — | Outperform |
| Jul 14, 2025 | TD Cowen | Initiated | — | Buy |
| Jul 14, 2025 | Guggenheim | Initiated | — | Buy |
| Jul 14, 2025 | Wolfe Research | Initiated | — | Outperform |